IR CANCELLED; US REGISTRATION CANCELLED
on 21 Dec 2020
Last Applicant/ Owned by
20 Primrose Street; London EC2A 2RS
GB
Serial Number
79097713 filed on 21st Dec 2010
Registration Number
4037134 registered on 11th Oct 2011
Correspondent Address
Suffolk IP22 1HX, United Kingdom
Filing Basis
No Filing Basis
Disclaimer
NO DATA
OMONTYS
Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Mark Details
Serial Number
No 79097713
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Nov 2021 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| 07th Nov 2021 | DEATH OF INTERNATIONAL REGISTRATION |
| 08th Mar 2019 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 31st Jan 2019 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 31st Jan 2019 | INVALIDATION PROCESSED |
| 18th Jan 2019 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 18th May 2018 | CANCELLED SECTION 71 |
| 04th Aug 2016 | NEW REPRESENTATIVE AT IB RECEIVED |
| 23rd Jun 2012 | NOTIFICATION PROCESSED BY IB |
| 22nd Mar 2012 | FINAL DISPOSITION NOTICE SENT TO IB |